Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
Hagerty, Inc.
HGTY·Financials
A ★★★★Buy
Current$12.81
Target$14.88
Return+16.2%
Aug 19, 2026

Hagerty is a monopolistic, highly profitable tollbooth on the multi-billion-dollar collector car ecosystem with compounding structural growth, though investors must vigilantly monitor underwriting volatility as the firm transitions to retaining 100% of its insurance risk.

Score
86
Planet Fitness, Inc.
PLNT·Consumer Discretionary
B ★★★Hold
Current$50.63
Target$67.47
Return+33.3%
Aug 19, 2026

Planet Fitness is an elite, high-ROIC cash compounder trading at a historically distressed valuation, but investors must endure severe near-term turbulence stemming from a highly leveraged balance sheet and a totally stalled membership acquisition funnel.

Score
76
Atmus Filtration Technologies Inc.
ATMU·Consumer Discretionary
B ★★★Hold
Current$50.08
Target$59.04
Return+17.9%
Aug 19, 2026

Atmus Filtration operates a wildly profitable, cash-printing aftermarket monopoly in heavy-duty commercial vehicles that trades at a steep discount to peers, though investors must remain acutely vigilant regarding the long-term existential decay of the global diesel engine market.

Score
84
Marex Group Limited
MRX·Financials
A ★★★★Buy
Current$71.06
Target$90.00
Return+26.7%
Aug 19, 2026

Marex is an exceptionally profitable, rapidly compounding financial infrastructure tollbooth trading at a wildly discounted 11.5x forward multiple, though investors must remain deeply vigilant against the mechanical compression of net interest income if central banks aggressively slash global interest rates.

Score
85
Envista Holdings Corporation
NVST·Healthcare
B ★★★Hold
Current$28.52
Target$29.70
Return+4.1%
Aug 18, 2026

Envista is executing a highly profitable, extraordinarily cash-generative turnaround fueled by market share gains in clear aligners, though its premium valuation requires investors to remain highly vigilant regarding the vulnerability of elective dentistry to consumer recessions.

Score
75
LivaNova PLC
LIVN·Healthcare
A ★★★★Buy
Current$81.48
Target$91.35
Return+12.1%
Aug 18, 2026

LivaNova is a deeply entrenched medical device compounder perfectly positioned to harvest explosive margin expansion from recent Medicare reimbursement hikes, though investors must tolerate near-term execution risk surrounding its critical supply chain scale-up and sleep apnea regulatory filings.

Score
86
IPG Photonics Corporation
IPGP·Technology
C ★★Sell
Current$85.79
Aug 18, 2026

IPG Photonics remains a premier, cash-rich technological innovator successfully diversifying into high-margin medical and defense markets, but severe cyclical headwinds and punishing geopolitical restructuring costs render its current valuation mathematically uninvestable in the near term.

Score
58
Excelerate Energy, Inc.
EE·Energy
A ★★★★Buy
Current$36.63
Target$43.66
Return+19.2%
Aug 18, 2026

Excelerate has masterfully transformed into an integrated, cash-printing global LNG utility trading at a deeply misunderstood growth multiple, though investors must stomach the inherent geopolitical volatility of its emerging-market sovereign counterparties.

Score
86
International Bancshares Corporation
IBOC·Financials
B ★★★Hold
Current$73.38
Target$85.00
Return+15.8%
Aug 18, 2026

International Bancshares commands an elite, structurally unrivaled border deposit franchise capable of generating massive ROA, yet its premium valuation and sudden, acute struggle with non-performing commercial real estate loans suggest investors should wait for absolute balance sheet stabilization before initiating new positions.

Score
76
Hamilton Lane Incorporated
HLNE·Financials
A ★★★★Buy
Current$104.24
Target$135.54
Return+30.0%
Aug 18, 2026

Hamilton Lane operates as the premier, indispensable toll-collector of the expanding private markets ecosystem, trading at an undeniable cash-flow discount despite boasting 30%+ ROE, though investors must navigate the cyclical lumpiness of its massive, yet macro-dependent, carried interest realizations.

Score
92
Nelnet, Inc.
NNI·Financials
A ★★★★Buy
Current$127.79
Target$140.00
Return+9.6%
Aug 18, 2026

Nelnet is an exceptional capital-compounding machine disguised as a boring student loan servicer, using massive cash flows from an amortizing legacy portfolio to fund highly profitable tech and banking ventures at a deep discount to its true sum-of-the-parts intrinsic value.

Score
86
Brookfield Infrastructure Corporation
BIPC·Utilities
S ★★★★★Strong Buy
Current$40.44
Target$48.96
Return+21.1%
Aug 17, 2026

Brookfield Infrastructure is an apex operator of monopolistic global assets trading at a highly compressed multiple ahead of a massive index-inclusion catalyst, though investors must tolerate the headline volatility induced by its heavily leveraged, asset-level financing structure.

Score
95